Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Shashank Sinha

Advanced Heart Failure · Inova Fairfax Hospital

View

Dr. Javed Butler

Advanced Heart Failure · Baylor Health Care System

View

Dr. Andrew Sauer

Advanced Heart Failure · Saint Luke's

View

Dr. Anu Lala

Advanced Heart Failure · Mount Sinai

View

Dr. Robert Mentz

Advanced Heart Failure · Duke University

View

Dr. Stephanie Hsiao

Advanced Heart Failure · Stanford

View

Dr. Michelle Kittleson

Advanced Heart Failure · Cedars-Sinai

View

Dr. Adrian Hernandez

Advanced Heart Failure · Duke

View

Dr. Dorairaj Prabhakaran

General Cardiology

View

Dr. Pugazhendhi Vijayaraman

EP · Geisinger

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Characteristics and Outcomes of Patients With Cardiogenic Shock and Clinically Significant Valvular Heart Disease: From the Critical Care Cardiology Trials Network.

    Feb 17, 2025DOI: 10.1016/j.cardfail.2025.01.019Journal ArticleJCF

    Written by: Anthony P CarnicelliP Elliott MillerDavid D BergNijat AliyevCarlos L AlviarErin A BohulaSunit-Preet ChaudhryMeshe ChondeChristine ChowHoward A CooperLori B DanielsChristopher B FordyceShahab GhafghaziMichael J GoldfarbKari L GorderMadeleine M HamiltonRyan R KeaneMichael C KontosJonathan J KusnerEvan LeibnerDaniel B LoriauxVenu MenonRaunak M NairL Kristin NewbyMary-Tiffany OduahMichael G PalazzoloHarsh PatoliaJacob B PierceMatthew J PierceBrian J PotterAlastair ProudfootRobert O RoswelGregory SchnellJeffrey ShawKiran SidhuShashank S SinhaAnubodh S VarshneyJason N KatzSean VAN DiepenDavid A Morrow

    Find these authors on Roon

    SC

    Dr. Sunit-Preet Chaudhry

    Advanced Heart Failure · Ascension St. Vincent Hospital

    EL

    Dr. Evan Leibner

    Critical Care · Mount Sinai

    SV

    Dr. Sunny Varshney

    Advanced Heart Failure · Stanford

    Summary

    BACKGROUND: Cardiogenic shock (CS) can be complicated by severe valvular heart disease (VHD). We analyzed cardiac intensive care unit (CICU) admissions according to VHD status.METHODS AND RESULTS: The Critical Care Cardiology Trials Network is a multicenter network of tertiary CICUs. Centers contributed data from consecutive admissions during 2-month annual snapshots from 2017-2023. CS admissions were classified as having CS attributed to VHD, CS with noncausative VHD or CS without severe VHD. Demographics and therapies were compared. Unadjusted and adjusted odds ratios for in-hospital mortality were calculated. We analyzed 5242 admissions with CS (4.1% attributed to VHD, 18.8% with noncausative VHD, 77.1% without severe VHD). Mitral regurgitation (32.1%) and aortic stenosis (27.9%) were the most common pathologies in CS attributed to VHD. Admissions with CS attributed to VHD more commonly had LVEF ≥ 40% on admission (present in 62.8%, 22.6% and 15.1%, respectively; P < 0.001). Valve intervention was performed in 32.1% of those with CS attributed to VHD. Unadjusted in-hospital mortality in admissions with CS attributed to VHD was 40.0%, compared to 33.4% and 30.3% in the other groups.CONCLUSIONS: VHD is the underlying cause of CS in a minority of CICU admissions but is associated with high in-hospital mortality rates.
    SVDr. Sunny Varshney
    Leading Voice

    Dr. Sunny Varshney

    Cardiology · Advanced Heart Failure & Transplantation
    Stanford Medicine
    sunny
    Stanford, CA